Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity-Reference-Cited by-同舟云学术

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity

Published:2001-08 Issue:8 Volume:7 Page:954-960
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Ichikawa Kimihisa,Liu Weimin,Zhao Limin,Wang Zheng,Liu Di,Ohtsuka Toshiaki,Zhang Huangge,Mountz John D.,Koopman William J.,Kimberly Robert P.,Zhou Tong

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm0801_954.pdf

Reference26 articles.

1. Wiley, S.R. et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673–682 (1995).

2. Sheridan, J.P. et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277, 818–821 (1997).

3. Walczak, H. et al. Tumoricidal activity of tumor necrosis factor-related apoptosis- inducing ligand in vivo. Nature Med 5, 157–163 (1999).

4. Ashkenazi, A. et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104, 155–162 (1999).

5. Pan, G. et al. The receptor for the cytotoxic ligand TRAIL. Science 276, 111–113 (1997).

Cited by 498 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PEG-lipid-modified agonistic antibody against tumor necrosis factor receptor family elicits superior apoptosis-inducing activity against human carcinoma;Bioorganic & Medicinal Chemistry Letters;2024-09

2. Nanoparticle-mediated gene delivery of TRAIL to resistant cancer cells: A review;Heliyon;2024-08

3. SH003 Induces DR5-Mediated Caspase-Dependent Apoptosis of NSCLC Through Inhibition of AKT Survival Pathway;Natural Product Communications;2024-08

4. MiR-29 and MiR-140 regulate TRAIL-induced drug tolerance in lung cancer;Animal Cells and Systems;2024-04-30

5. Principles and therapeutic applications of adaptive immunity;Cell;2024-04